Systemic mastocytosis is a rare health condition in which too many mast cells (a type of immune system cell) build up in the body, causing allergic reactions and other health issues. This disorder ...

Citation: Advances in systemic mastocytosis: Early signs of efficacy for novel drug and new predictive tool to guide patient care (2024, December 9) retrieved 5 January 2025 from https ...

In September of 2000, the world's leading experts in MC met to discuss and present data at the "Year 2000 Working Conference on Mastocytosis," held in Vienna, Austria. Table 1 presents a uniform ...

DeAngelo, Shimony, and Volpe combed through data from three previous clinical trials of an earlier KIT D816V inhibitor, called avapritinib. These trials -; EXPLORER (NCT02561988), PATHFINDER ...

Analyst Silvan Tuerkcan of JMP Securities reiterated a Buy rating on Allakos (ALLK – Research Report), with a price target of $3.00.Stay Ahead ...

Systemic mastocytosis (SM) is a rare disease driven by the KIT D816V mutation in about 95 percent of cases. Uncontrolled proliferation and activation of mast cells result in chronic, severe and ...

and gastrointestinal stromal tumors as well as aggressive systematic mastocytosis, hypereosinophilic syndrome, chronic eosinophilic leukemia, and dermatofibrosarcoma protuberans. FDA Approves ...

"Fast Facts: Systemic Mastocytosis" and "Fast Facts: CAR-T-Cell Therapy in Diffuse Large B-Cell Lymphoma" are also available, offering insights into niche areas of hematology. Whether you are ...